4-(4-nitrobenzyl)pyridine has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, JA; Sartorelli, AC; Shiba, DA | 1 |
| Najman-Bronzewska, L; Ochocki, J | 1 |
2 other study(ies) available for 4-(4-nitrobenzyl)pyridine and Leukemia L 1210
| Article | Year |
|---|---|
Relationship of spontaneous chemical transformation of arylsulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide to anticancer activity.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; Half-Life; Humans; Hydrazones; Leukemia L1210; Mice; Nicotinyl Alcohol; Pyridines; Sarcoma, Experimental; Structure-Activity Relationship | 1983 |
In vitro alkylating of alpha, beta-unsaturated amidoesters, diethyl pyridylmethylphosphonates and their cis-Pt(II)complexes.
Topics: Amides; Animals; Antineoplastic Agents, Alkylating; Drug Screening Assays, Antitumor; Esters; Indicators and Reagents; Leukemia L1210; Mice; Organophosphonates; Organoplatinum Compounds; Pyridines; Sarcoma 180 | 1997 |